Cargando…
Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model
Autores principales: | Goettel, Jeremy A., Kotlarz, Daniel, Emani, Rohini, Canavan, James B., Konnikova, Liza, Illig, David, Frei, Sandra M., Field, Michael, Kowalik, Matthew, Peng, Kaiyue, Gringauz, Jordan, Mitsialis, Vanessa, Wall, Sarah M., Tsou, Amy, Griffith, Alexandra E., Huang, Ying, Friedman, Joshua R., Towne, Jennifer E., Plevy, Scott E., O’Hara Hall, Aisling, Snapper, Scott B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661391/ https://www.ncbi.nlm.nih.gov/pubmed/31078723 http://dx.doi.org/10.1016/j.jcmgh.2019.05.001 |
Ejemplares similares
-
Utilizing a reductionist model to study host-microbe interactions in intestinal inflammation
por: Tsou, Amy M., et al.
Publicado: (2021) -
WASP-mediated regulation of anti-inflammatory macrophages is IL-10 dependent and is critical for intestinal homeostasis
por: Biswas, Amlan, et al.
Publicado: (2018) -
Dysregulated inflammasome activity in intestinal inflammation – Insights from patients with very early onset IBD
por: Illig, David, et al.
Publicado: (2022) -
CD16(+)CD163(+) monocytes traffic to sites of inflammation during necrotizing enterocolitis in premature infants
por: Olaloye, Oluwabunmi O., et al.
Publicado: (2021) -
RIPK1 mutations causing infantile-onset IBD with inflammatory and fistulizing features
por: Sultan, Mutaz, et al.
Publicado: (2022)